Successful outcome with reduced-intensity condition regimen followed by allogeneic hematopoietic stem cell transplantation for relapsed or refractory anaplastic large-cell lymphoma-Reference-Cited by-同舟云学术

Successful outcome with reduced-intensity condition regimen followed by allogeneic hematopoietic stem cell transplantation for relapsed or refractory anaplastic large-cell lymphoma

Published:2019-10-16 Issue:6 Volume:110 Page:723-728
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Fukano Reiji^ORCID,Mori Tetsuya,Fujita Naoto,Kobayashi Ryoji,Mitsui Tetsuo,Kato Koji,Suzuki Ritsuro,Suzumiya Junji,Fukuda Takahiro,Shindo Motohiro,Maseki Nobuo,Shimoyama Tatsu,Okada Keiko,Inoue Masami,Inagaki Jiro,Hashii Yoshiko,Sato Atsushi,Tabuchi Ken

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12185-019-02748-1.pdf

Reference13 articles.

1. Fukano R, Mori T, Kobayashi R, Mitsui T, Fujita N, Iwasaki F, et al. Haematopoietic stem cell transplantation for relapsed or refractory anaplastic large cell lymphoma: a study of children and adolescents in Japan. Br J Haematol. 2015;168(4):557–63.

2. Yaniv I, Stein J, Party EPW. Reduced-intensity conditioning in children: a reappraisal in 2008. Bone Marrow Transplant. 2008;41(Suppl 2):S18–22.

3. Giralt S, Ballen K, Rizzo D, Bacigalupo A, Horowitz M, Pasquini M, et al. Reduced-intensity conditioning regimen workshop: defining the dose spectrum Report of a workshop convened by the center for international blood and marrow transplant research. Biol Blood Marrow Transplant. 2009;15(3):367–9.

4. Ohta H, Kusuki S, Yoshida H, Sato E, Hashii Y, Ozono K. Allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning for a child with recurrent anaplastic large cell lymphoma. Int J Hematol. 2010;92(1):190–3.

5. Luger SM, Ringden O, Zhang MJ, Perez WS, Bishop MR, Bornhauser M, et al. Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS. Bone Marrow Transplant. 2012;47(2):203–11.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategy for Pediatric Patients with Relapsed or Refractory Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma: A Review;Cancers;2023-12-07

2. Diagnosis and management of ALK-positive anaplastic large cell lymphoma in children and adolescents;Best Practice & Research Clinical Haematology;2023-03

3. ALK陽性未分化大細胞リンパ腫に対する新規治療法の開発;Yamaguchi Medical Journal;2022-12-01

4. Allogeneic haematopoietic cell transplant in patients with relapsed/refractory anaplastic large cell lymphoma—Response;British Journal of Haematology;2022-10-19

5. Characteristics and Outcomes of Chinese Children With Advanced Stage Anaplastic Large Cell Lymphoma: A Single-Center Experience;Frontiers in Oncology;2022-02-15